カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の経口コレラ生ワクチン市場予測2023-2029：Dukoral、Shanchol、Vaxchora、その他

【英語タイトル】Cholera Vaccines Oral Live Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8412）・商品コード：MMG23LY8412
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：73
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の経口コレラ生ワクチン市場規模と予測を収録しています。・世界の経口コレラ生ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の経口コレラ生ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経口コレラ生ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Dukoral」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

経口コレラ生ワクチンのグローバル主要企業は、Valneva、 PaxVax、 Shantha Biotechnics Limited、 Celldex Therapeutics、 Merck、 Ceva Asiaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、経口コレラ生ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の経口コレラ生ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の経口コレラ生ワクチン市場：タイプ別市場シェア、2022年
・Dukoral、Shanchol、Vaxchora、その他

世界の経口コレラ生ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の経口コレラ生ワクチン市場：用途別市場シェア、2022年
・病院、科学研究、その他

世界の経口コレラ生ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の経口コレラ生ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における経口コレラ生ワクチンのグローバル売上、2018年-2023年
・主要企業における経口コレラ生ワクチンのグローバル売上シェア、2022年
・主要企業における経口コレラ生ワクチンのグローバル販売量、2018年-2023年
・主要企業における経口コレラ生ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Valneva、 PaxVax、 Shantha Biotechnics Limited、 Celldex Therapeutics、 Merck、 Ceva Asia

*************************************************************

・調査・分析レポートの概要
経口コレラ生ワクチン市場の定義
市場セグメント
世界の経口コレラ生ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経口コレラ生ワクチン市場規模
世界の経口コレラ生ワクチン市場規模：2022年 VS 2029年
世界の経口コレラ生ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経口コレラ生ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経口コレラ生ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Dukoral、Shanchol、Vaxchora、その他
経口コレラ生ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、科学研究、その他
経口コレラ生ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別経口コレラ生ワクチン市場規模 2022年と2029年
地域別経口コレラ生ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Valneva、 PaxVax、 Shantha Biotechnics Limited、 Celldex Therapeutics、 Merck、 Ceva Asia
...

Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
This report aims to provide a comprehensive presentation of the global market for Cholera Vaccines Oral Live, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholera Vaccines Oral Live. This report contains market size and forecasts of Cholera Vaccines Oral Live in global, including the following market information:
Global Cholera Vaccines Oral Live Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cholera Vaccines Oral Live Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cholera Vaccines Oral Live companies in 2022 (%)
The global Cholera Vaccines Oral Live market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dukoral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cholera Vaccines Oral Live include Valneva, PaxVax, Shantha Biotechnics Limited, Celldex Therapeutics, Merck and Ceva Asia, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cholera Vaccines Oral Live manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cholera Vaccines Oral Live Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cholera Vaccines Oral Live Market Segment Percentages, by Type, 2022 (%)
Dukoral
Shanchol
Vaxchora
Others
Global Cholera Vaccines Oral Live Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cholera Vaccines Oral Live Market Segment Percentages, by Application, 2022 (%)
Hospital
Scientific Research
Others
Global Cholera Vaccines Oral Live Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cholera Vaccines Oral Live Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cholera Vaccines Oral Live revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cholera Vaccines Oral Live revenues share in global market, 2022 (%)
Key companies Cholera Vaccines Oral Live sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cholera Vaccines Oral Live sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cholera Vaccines Oral Live, market overview.
Chapter 2: Global Cholera Vaccines Oral Live market size in revenue and volume.
Chapter 3: Detailed analysis of Cholera Vaccines Oral Live manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cholera Vaccines Oral Live in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cholera Vaccines Oral Live capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cholera Vaccines Oral Live Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cholera Vaccines Oral Live Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cholera Vaccines Oral Live Overall Market Size
2.1 Global Cholera Vaccines Oral Live Market Size: 2022 VS 2029
2.2 Global Cholera Vaccines Oral Live Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cholera Vaccines Oral Live Sales: 2018-2029
3 Company Landscape
3.1 Top Cholera Vaccines Oral Live Players in Global Market
3.2 Top Global Cholera Vaccines Oral Live Companies Ranked by Revenue
3.3 Global Cholera Vaccines Oral Live Revenue by Companies
3.4 Global Cholera Vaccines Oral Live Sales by Companies
3.5 Global Cholera Vaccines Oral Live Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cholera Vaccines Oral Live Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cholera Vaccines Oral Live Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cholera Vaccines Oral Live Players in Global Market
3.8.1 List of Global Tier 1 Cholera Vaccines Oral Live Companies
3.8.2 List of Global Tier 2 and Tier 3 Cholera Vaccines Oral Live Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cholera Vaccines Oral Live Market Size Markets, 2022 & 2029
4.1.2 Dukoral
4.1.3 Shanchol
4.1.4 Vaxchora
4.1.5 Others
4.2 By Type – Global Cholera Vaccines Oral Live Revenue & Forecasts
4.2.1 By Type – Global Cholera Vaccines Oral Live Revenue, 2018-2023
4.2.2 By Type – Global Cholera Vaccines Oral Live Revenue, 2024-2029
4.2.3 By Type – Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
4.3 By Type – Global Cholera Vaccines Oral Live Sales & Forecasts
4.3.1 By Type – Global Cholera Vaccines Oral Live Sales, 2018-2023
4.3.2 By Type – Global Cholera Vaccines Oral Live Sales, 2024-2029
4.3.3 By Type – Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
4.4 By Type – Global Cholera Vaccines Oral Live Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cholera Vaccines Oral Live Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application – Global Cholera Vaccines Oral Live Revenue & Forecasts
5.2.1 By Application – Global Cholera Vaccines Oral Live Revenue, 2018-2023
5.2.2 By Application – Global Cholera Vaccines Oral Live Revenue, 2024-2029
5.2.3 By Application – Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
5.3 By Application – Global Cholera Vaccines Oral Live Sales & Forecasts
5.3.1 By Application – Global Cholera Vaccines Oral Live Sales, 2018-2023
5.3.2 By Application – Global Cholera Vaccines Oral Live Sales, 2024-2029
5.3.3 By Application – Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
5.4 By Application – Global Cholera Vaccines Oral Live Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cholera Vaccines Oral Live Market Size, 2022 & 2029
6.2 By Region – Global Cholera Vaccines Oral Live Revenue & Forecasts
6.2.1 By Region – Global Cholera Vaccines Oral Live Revenue, 2018-2023
6.2.2 By Region – Global Cholera Vaccines Oral Live Revenue, 2024-2029
6.2.3 By Region – Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
6.3 By Region – Global Cholera Vaccines Oral Live Sales & Forecasts
6.3.1 By Region – Global Cholera Vaccines Oral Live Sales, 2018-2023
6.3.2 By Region – Global Cholera Vaccines Oral Live Sales, 2024-2029
6.3.3 By Region – Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cholera Vaccines Oral Live Revenue, 2018-2029
6.4.2 By Country – North America Cholera Vaccines Oral Live Sales, 2018-2029
6.4.3 US Cholera Vaccines Oral Live Market Size, 2018-2029
6.4.4 Canada Cholera Vaccines Oral Live Market Size, 2018-2029
6.4.5 Mexico Cholera Vaccines Oral Live Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cholera Vaccines Oral Live Revenue, 2018-2029
6.5.2 By Country – Europe Cholera Vaccines Oral Live Sales, 2018-2029
6.5.3 Germany Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.4 France Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.5 U.K. Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.6 Italy Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.7 Russia Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.8 Nordic Countries Cholera Vaccines Oral Live Market Size, 2018-2029
6.5.9 Benelux Cholera Vaccines Oral Live Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cholera Vaccines Oral Live Revenue, 2018-2029
6.6.2 By Region – Asia Cholera Vaccines Oral Live Sales, 2018-2029
6.6.3 China Cholera Vaccines Oral Live Market Size, 2018-2029
6.6.4 Japan Cholera Vaccines Oral Live Market Size, 2018-2029
6.6.5 South Korea Cholera Vaccines Oral Live Market Size, 2018-2029
6.6.6 Southeast Asia Cholera Vaccines Oral Live Market Size, 2018-2029
6.6.7 India Cholera Vaccines Oral Live Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cholera Vaccines Oral Live Revenue, 2018-2029
6.7.2 By Country – South America Cholera Vaccines Oral Live Sales, 2018-2029
6.7.3 Brazil Cholera Vaccines Oral Live Market Size, 2018-2029
6.7.4 Argentina Cholera Vaccines Oral Live Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cholera Vaccines Oral Live Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cholera Vaccines Oral Live Sales, 2018-2029
6.8.3 Turkey Cholera Vaccines Oral Live Market Size, 2018-2029
6.8.4 Israel Cholera Vaccines Oral Live Market Size, 2018-2029
6.8.5 Saudi Arabia Cholera Vaccines Oral Live Market Size, 2018-2029
6.8.6 UAE Cholera Vaccines Oral Live Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Valneva
7.1.1 Valneva Company Summary
7.1.2 Valneva Business Overview
7.1.3 Valneva Cholera Vaccines Oral Live Major Product Offerings
7.1.4 Valneva Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.1.5 Valneva Key News & Latest Developments
7.2 PaxVax
7.2.1 PaxVax Company Summary
7.2.2 PaxVax Business Overview
7.2.3 PaxVax Cholera Vaccines Oral Live Major Product Offerings
7.2.4 PaxVax Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.2.5 PaxVax Key News & Latest Developments
7.3 Shantha Biotechnics Limited
7.3.1 Shantha Biotechnics Limited Company Summary
7.3.2 Shantha Biotechnics Limited Business Overview
7.3.3 Shantha Biotechnics Limited Cholera Vaccines Oral Live Major Product Offerings
7.3.4 Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.3.5 Shantha Biotechnics Limited Key News & Latest Developments
7.4 Celldex Therapeutics
7.4.1 Celldex Therapeutics Company Summary
7.4.2 Celldex Therapeutics Business Overview
7.4.3 Celldex Therapeutics Cholera Vaccines Oral Live Major Product Offerings
7.4.4 Celldex Therapeutics Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.4.5 Celldex Therapeutics Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Cholera Vaccines Oral Live Major Product Offerings
7.5.4 Merck Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Ceva Asia
7.6.1 Ceva Asia Company Summary
7.6.2 Ceva Asia Business Overview
7.6.3 Ceva Asia Cholera Vaccines Oral Live Major Product Offerings
7.6.4 Ceva Asia Cholera Vaccines Oral Live Sales and Revenue in Global (2018-2023)
7.6.5 Ceva Asia Key News & Latest Developments
8 Global Cholera Vaccines Oral Live Production Capacity, Analysis
8.1 Global Cholera Vaccines Oral Live Production Capacity, 2018-2029
8.2 Cholera Vaccines Oral Live Production Capacity of Key Manufacturers in Global Market
8.3 Global Cholera Vaccines Oral Live Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cholera Vaccines Oral Live Supply Chain Analysis
10.1 Cholera Vaccines Oral Live Industry Value Chain
10.2 Cholera Vaccines Oral Live Upstream Market
10.3 Cholera Vaccines Oral Live Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cholera Vaccines Oral Live Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cholera Vaccines Oral Live in Global Market
Table 2. Top Cholera Vaccines Oral Live Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cholera Vaccines Oral Live Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cholera Vaccines Oral Live Revenue Share by Companies, 2018-2023
Table 5. Global Cholera Vaccines Oral Live Sales by Companies, (K Units), 2018-2023
Table 6. Global Cholera Vaccines Oral Live Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cholera Vaccines Oral Live Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Cholera Vaccines Oral Live Product Type
Table 9. List of Global Tier 1 Cholera Vaccines Oral Live Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cholera Vaccines Oral Live Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cholera Vaccines Oral Live Sales (K Units), 2018-2023
Table 15. By Type - Global Cholera Vaccines Oral Live Sales (K Units), 2024-2029
Table 16. By Application – Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cholera Vaccines Oral Live Sales (K Units), 2018-2023
Table 20. By Application - Global Cholera Vaccines Oral Live Sales (K Units), 2024-2029
Table 21. By Region – Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cholera Vaccines Oral Live Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cholera Vaccines Oral Live Sales (K Units), 2018-2023
Table 25. By Region - Global Cholera Vaccines Oral Live Sales (K Units), 2024-2029
Table 26. By Country - North America Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cholera Vaccines Oral Live Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cholera Vaccines Oral Live Sales, (K Units), 2018-2023
Table 29. By Country - North America Cholera Vaccines Oral Live Sales, (K Units), 2024-2029
Table 30. By Country - Europe Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cholera Vaccines Oral Live Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cholera Vaccines Oral Live Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cholera Vaccines Oral Live Sales, (K Units), 2024-2029
Table 34. By Region - Asia Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cholera Vaccines Oral Live Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cholera Vaccines Oral Live Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cholera Vaccines Oral Live Sales, (K Units), 2024-2029
Table 38. By Country - South America Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cholera Vaccines Oral Live Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cholera Vaccines Oral Live Sales, (K Units), 2018-2023
Table 41. By Country - South America Cholera Vaccines Oral Live Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cholera Vaccines Oral Live Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cholera Vaccines Oral Live Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cholera Vaccines Oral Live Sales, (K Units), 2024-2029
Table 46. Valneva Company Summary
Table 47. Valneva Cholera Vaccines Oral Live Product Offerings
Table 48. Valneva Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Valneva Key News & Latest Developments
Table 50. PaxVax Company Summary
Table 51. PaxVax Cholera Vaccines Oral Live Product Offerings
Table 52. PaxVax Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. PaxVax Key News & Latest Developments
Table 54. Shantha Biotechnics Limited Company Summary
Table 55. Shantha Biotechnics Limited Cholera Vaccines Oral Live Product Offerings
Table 56. Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Shantha Biotechnics Limited Key News & Latest Developments
Table 58. Celldex Therapeutics Company Summary
Table 59. Celldex Therapeutics Cholera Vaccines Oral Live Product Offerings
Table 60. Celldex Therapeutics Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Celldex Therapeutics Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Cholera Vaccines Oral Live Product Offerings
Table 64. Merck Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Ceva Asia Company Summary
Table 67. Ceva Asia Cholera Vaccines Oral Live Product Offerings
Table 68. Ceva Asia Cholera Vaccines Oral Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Ceva Asia Key News & Latest Developments
Table 70. Cholera Vaccines Oral Live Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Cholera Vaccines Oral Live Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Cholera Vaccines Oral Live Production by Region, 2018-2023 (K Units)
Table 73. Global Cholera Vaccines Oral Live Production by Region, 2024-2029 (K Units)
Table 74. Cholera Vaccines Oral Live Market Opportunities & Trends in Global Market
Table 75. Cholera Vaccines Oral Live Market Drivers in Global Market
Table 76. Cholera Vaccines Oral Live Market Restraints in Global Market
Table 77. Cholera Vaccines Oral Live Raw Materials
Table 78. Cholera Vaccines Oral Live Raw Materials Suppliers in Global Market
Table 79. Typical Cholera Vaccines Oral Live Downstream
Table 80. Cholera Vaccines Oral Live Downstream Clients in Global Market
Table 81. Cholera Vaccines Oral Live Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cholera Vaccines Oral Live Segment by Type in 2022
Figure 2. Cholera Vaccines Oral Live Segment by Application in 2022
Figure 3. Global Cholera Vaccines Oral Live Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cholera Vaccines Oral Live Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cholera Vaccines Oral Live Revenue, 2018-2029 (US$, Mn)
Figure 7. Cholera Vaccines Oral Live Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cholera Vaccines Oral Live Revenue in 2022
Figure 9. By Type - Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 12. By Type - Global Cholera Vaccines Oral Live Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 16. By Application - Global Cholera Vaccines Oral Live Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Cholera Vaccines Oral Live Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cholera Vaccines Oral Live Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 21. By Country - North America Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 23. US Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 28. Germany Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 29. France Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 37. China Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 41. India Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 44. Brazil Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cholera Vaccines Oral Live Sales Market Share, 2018-2029
Figure 48. Turkey Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cholera Vaccines Oral Live Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cholera Vaccines Oral Live Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Cholera Vaccines Oral Live by Region, 2022 VS 2029
Figure 54. Cholera Vaccines Oral Live Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の経口コレラ生ワクチン市場予測2023-2029：Dukoral、Shanchol、Vaxchora、その他] (コード：MMG23LY8412)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経口コレラ生ワクチン市場予測2023-2029：Dukoral、Shanchol、Vaxchora、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の豚流行性下痢ワクチン市場予測2023-2029：生ワクチン、死菌ワクチン
  • 世界の鶏用ワクチン市場予測2023-2029：生ワクチン、不活化ワクチン、
  • 世界のポリオワクチン市場予測2023-2029：IPV、OPV
  • 世界の弱毒生水痘ワクチン市場予測2023-2029：一価ワクチン、混合ワクチン
  • 世界のブタ用ワクチン市場予測2023-2029：CSFワクチン、口蹄疫ワクチン、豚サーコウイルスワクチン、PRRSワクチン、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆